Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5873_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
372 Chapter 14 Diabetes mellitus and obesity
O/E:
1) Ulcer is warm and pus-filled
2) Pedal (foot) pulses are absent
3) Pinprick sensation is absent
4) Patient is extremely lethargic
5) Temperature: 38.9°C (reference 37°C)
6) BP = 140/80 mmHg (reference < 140/90 mmHg)
7) BMI = 31 kg/m
Andreas’s ulcer has resulted from peripheral neuropathy and ischaemia to his toes. This is confirmed by the absence of a pedal pulse and the lack of sensation when his toes are pricked with a pin.
His temperature is elevated as a result of infection in the ulcerated area.
Biochemistry:
1) Random blood glucose level 38 mmol/l (reference 3.5–10.0 mmol/l)
2) Glycated haemoglobin = 9.7% (reference 4–6%)
3) White cell count = 16 × 109/l (reference = 4–9.5 × 109/l)
Urine testing:
1) Ketones: negative
2) Glucose: positive
1) Andreas’s blood glucose level taken at random is extremely elevated, indicative of diabetes.
2) HbA1C is haemoglobin that has been modified through an irreversible reaction with glucose. This gives a convenient index of glucose control over the past 120 days (the lifespan of a red blood cell), and is less variable than blood glucose levels. Andreas’s glycated haemoglobin (HbA1C) level is elevated, indicating that his blood glucose levels are poorly controlled.
2
3) Diabetic foot ulcers are prone to infection, explaining Andreas’s raised white cell count.
4) Ketone bodies appear in the urine in severe diabetes because of the uncontrolled breakdown of fats and proteins in the liver, which generates ketone bodies (acetoacetic acid and
-hydroxybutyric acid). This leads to muscle wasting. If levels of ketone bodies accumulate, ketoacidosis occurs which can be life-threatening. This is more common in type I diabetes. Andreas’s urine ketone level is not elevated.
5) When the concentration of glucose in the blood exceeds the kidneys’ capacity for reabsorption (around 10 mmol/l), glucose will appear in the urine. The glucose is accompanied by water, leading to an increased urinary frequency.
Diagnosis: Type II diabetes mellitus, infected ulcerated toe
Plan:
Send swabs and blood cultures from ulcer site to microbiology department
Intravenous antibiotics to treat infection
Start oral antidiabetic drug
Start soluble insulin infusion until blood glucose level <11 mmol/l
WORKBOOK 11 Diabetes mellitus and obesity 373
The doctor explains to Andreas that he has had undiagnosed diabetes for a while. This has already led to long-term complications like the ulcer, as well as immediate complications.
1) What is diabetes mellitus?
2) Explain the meaning of the following:
Glycaemia
Glycosuria
Ketonuria
3) What happens to blood glucose levels in diabetes?
4a) Which hormone is principally responsible for decreasing the post-prandial levels of glucose?
4b) Which hormone is principally responsible for increasing levels of blood glucose between meals?
4c) Where specifically are these two hormones synthesized?
5a) Elaborate the steps by which glucose stimulates the release of insulin.
5b) List two other stimuli for insulin secretion besides glucose.
After 2 days on the insulin infusion, Andreas is fed up and asks the doctor when it will be discontinued. The doctor explains that he has been put on insulin because his blood glucose level was extremely high. The insulin infusion will help to control his blood glucose, and is being adjusted according to the current level. The doctor promises that once his blood glucose has
stabilized,theinsulinwillbestopped.
6a) What are the main cell types that depend on insulin for their uptake of glucose?
6b) How does insulin affect uptake in these cells?
7) What type of receptor does insulin act at?
8) What is the effect of insulin on the following?
Carbohydrate metabolism
Fat metabolism
Protein metabolism
The doctor explains to Andreas that his increased thirst and urinary frequency are symptoms of the diabetes.
374 Chapter 14 Diabetes mellitus and obesity
9) How do increased urinary frequency and thirst come about in diabetes?
Andreas asks to see the doctor because he is worried about a severe diabetic complication he has heard about called diabetic ketoacidosis. The doctor explains that this is unlikely with type II diabetes, but that it is a possible complication in type I diabetes.
10a) What is type I diabetes? How does it differ from type II?
10b) Which drug is essential for treating type I diabetes?
10c) What is ketoacidosis?
10d) Why is ketoacidosis much less likely in type II than in type I diabetes?
The doctor talks to Andreas about the plans for his treatment. The insulin has been stopped as his blood glucose levels are within the normal range. The antibiotic has been switched to oral.
The doctor tells Andreas that he will have to take medication for his diabetes. Initially it will be tablets, but eventually he might need insulin. Andreas seems worried and tells the doctor that he hates injections.
11) Why does insulin need to be injected?
12a) Insulin preparations are divided into three main groups according to speed of onset and duration of
action. What are the three main groups?
12b) Some insulin preparations are injected immediately before meals. Which class do they belong to, and why are they used?
The doctor reassures Andreas that his type II diabetes can for now be controlled with tablets.
The pharmacist and doctor discuss Andreas’s therapy. Two drugs are discussed: metformin and
thesulfonylureagliclazide.Thepharmacistsaysthatgliclazidemaynotbethebestchoice
because of one of its side effects.
13) Which side effect of sulfonylureas means that gliclazide may not be the best choice for Andreas?
Hint: What is Andreas’s BMI?
14) What is the mechanism of action of gliclazide?
The doctor agrees with the pharmacist that metformin is a better choice, and it is prescribed for Andreas.
WORKBOOK 11 Diabetes mellitus and obesity 375
15a) What are the beneficial effects of metformin?
15b) List the advantages of biguanides over some of the other classes of antidiabetic drugs.
Andreas complains to the pharmacist that he feels very bloated, and wonders if it could be the metformin.
16) How might you advise Andreas to take the drug so as to reduce the bloating effect?
Andreas is discharged from hospital because his blood glucose level has been within the
desiredrangefor3days,andhisulcerismuchimproved.Hisantihypertensivemedicationhas beenchanged.Heisnowtakingacalciumchannelblockerinplaceofthethiazide-likediuretic
(indapamide) because these can worsen hyperglycaemia.
He is discharged on the following medication:
• amlodipine
• losartan
• metformin
• dicloxacillin,for4moredays.
He is urged to make regular appointments with the diabetes nurse at his surgery for advice and monitoring.
MANAGING DIABETES
Andreas attends his local surgery for appointments with the specialist diabetes nurse. His blood pressure and weight are routinely measured. He also has blood samples taken to measure cholesterol and glycated haemoglobin levels.
The nurse speaks to Andreas about the need for controlling his blood glucose levels and that, for now at least, this can be achieved through the use of oral diabetic medication. But she tells him that he needs to help himself by trying to lose weight, by modifying his diet and exercising more.
17a) Is Andreas obese? Explain the criteria for making this diagnosis.
17b) Explain the relationship between obesity and the development of diabetes
18) What is meant by the term insulin resistance?
376 Chapter 14 Diabetes mellitus and obesity
19) What is metabolic syndrome?
The nurse also informs Andreas about the long-term complications of diabetes and how it is important that he manages his condition in order to decrease his risk. This will also help reduce the rate of progression of the disease.
20a) Name some of the complications the diabetes nurse may have mentioned to Andreas.
20b) What is macrovascular disease?
20c) What is microvascular disease? Which organs/tissues are particularly affected?
Andreas has his blood pressure measurements taken every time he sees the diabetes nurse at
thesurgery.Histargetbloodpressureis130/80mmHg.
21a) Why is regulation of blood pressure important in diabetic patients?
21b) Why is target blood pressure for a diabetic patient lower than that for a non-diabetic patient?
Andreas’s cholesterol levels are also monitored closely during his visits. His levels of high density lipoprotein (HDL) and low density lipoprotein (LDL) are measured, along with total cholesterol. He is already taking simvastatin.
22) Why is it important to control blood cholesterol levels in diabetic patients?
23) Which lipoprotein is centrally involved in atherosclerosis?
24) How does simvastatin help to reduced cholesterol levels? (See Chapter 6, Section 6.2.2.)
After a few visits to the surgery, it is apparent that Andreas’s glycaemic control is not optimal. His HbA1C level is routinely higher than his target 7%. Further drug treatment is necessary.
25) What is HbA1C and how is it used to monitor glycaemic control?
26) List some of the other classes of drugs that the nurse might consider adding to metformin.
27) Which class of antidiabetic drug has a beneficial blood pressure lowering effect? How is this brought
about?
Andreasisprescribedpioglitazonetotakealongsidemetformin.
WORKBOOK 11 Diabetes mellitus and obesity 377
28a) At what type of receptor does pioglitazone act?
28b) What are the effects of pioglitazone?
During this time Andreas has been trying hard to lose weight. He has modified his diet and exercises more, but over the months his weight fluctuates and is not consistently reduced.
The diabetes nurse suggests that he takes orlistat.
29a) Describe the mechanism of action of orlistat.
29b) What are its common adverse effects?
After 12 weeks of taking orlistat, Andreas’ weight loss is found to be minimal. The nurse discusses bariatric surgery with Andreas.
Andreas decides to have surgery; the outcome is very good. His control of blood glucose levels is soon improved and is controlled through use of metformin alone. Andreas avoids having to inject insulin as he had so feared.
Chapter 15
Thyroid disorders and pharmacological methods of contraception
Useful terms for this topic
Goitre: A swelling in the neck resulting from
enlargement of the thyroid gland.
Tetraiodothyronine (T4 or thyroxine): Thyroid
hormone with reduced biological activity compared with T3; may be regarded as a pro-hormone for T3.
Thyroglobulin: The large glycoprotein within the
structure of which thyroid hormones are synthesized.
Thyroid-stimulating hormone (TSH; also called
thyrotrophin): Hormone released from the anterior
pituitary. Acts on the thyroid gland to stimulate growth and synthesis of thyroid hormones.
Thyrotrophin-releasing hormone (TRH): Hormone
released from the hypothalamus. Acts on the anterior pituitary to stimulate secretion of thyroid-stimulating hormone.
Triiodothyronine (T3): The thyroid hormone with
greatest biological activity.
e thyroid gland is responsible for controlling the body’s basal metabolic rate, as well as having essential roles in growth and development. Virtually all cells are aected by the thyroid hormones it secretes, and this underlies the broad spectrum of symptoms experienced in thyroid dysfunction. In this chapter we consider the consequences of both decient and excessive secretion of thyroid hormones. In order to do so, we must rst consider the anatomy of the thyroid gland, and how thyroid hormones are synthesized. e regulation of the thyroid gland involves both the pituitary and hypothalamus, an understanding of which is necessary in order to appreciate the treatment of common thyroid diseases. In Workbook 12 at the end of this chapter Sunita is diagnosed with a hyperactive thyroid. She has Graves’ disease, the most common cause of hyperthyroidism. Whilst undergoing treatment for thyroid disease, Sunita is prescribed medication to prevent pregnancy. e second half of this chapter looks at the hormonal changes that occur during the female reproductive cycle, and how they can be controlled using pharmacological agents in order to prevent conception.

15.1 The thyroid gland

e thyroid weighs about 16–20 g, and is one of the largest endocrine glands. It consists of two lobes situated on either side of the trachea, and joined together by a narrow portion of tissue (the isthmus). It lies over the trachea in the lower neck area, the region commonly referred to as the Adam’s apple in men. e functional unit in the thyroid gland is the follicle—a single layer of cuboidal epithelial
(follicular) cells arranged spherically around a central lumen lled with homogenous colloid (Figure 15.1). e main constituent of this colloid is thyroglobulin, a large globular glycoprotein produced by the follicular cells and secreted into the follicle lumen. e thyroid hormones are synthesized by modication of tyrosine residues within the thyroglobulin structure (see below).
15.1 The thyroid gland 379
A. Normal Follicle
Basal membrane
Apical membrane
Reduced volume of colloid
Enlarged follicular cells,
reabsorbing colloid
Capillaries
Lumen containing thyroglobulin colloid
B. Hyperthyroid C. Hypothyroid
Increased volume of colloid
Flattened underactive
follicular cells
Figure 15.1 Structure of follicles within the thyroid gland.
(A) Follicles in the normal thyroid. Cuboidal epithelial cells are arranged spherically. The follicle lumen is filled with thyroglobulin-containing colloid. A rich network of capillaries surrounds the follicles. (B) In the underactive thyroid gland the follicles are distended with increased colloid, and the epithelial cells are thin and flattened. By contrast, in the overactive thyroid (C) the follicular cells are increased in size, and the colloid content reduced, due to increased reabsorption by the cells.
15.1.1 Synthesis and transport of thyroid
hormones
e thyroid gland produces two iodine-containing hormones: tetraiodothyronine (T4, or thyroxine) and triiodothyronine (T3).1 Synthesis of these hormones requires iodide (I–), which is obtained from the diet and delivered to the follicular cells in the blood, via the rich network of capillaries surrounding the follicles. Two separate transporters are involved in the movement of I− from the blood into the follicle lumen:
1 A third unrelated hormone, calcitonin, is synthesized in C cells, located between the follicles. is hormone is involved in Ca2+ metabolism, and is not considered further here.
1. e Na+/I− symporter captures I− from the blood and brings it into the follicular cells
2. e I−/Cl− transporter (pendrin) on the luminal membrane carries I− into the lumen.
e iodide is activated by oxidation. is reaction is catalysed by hydroperoxidase, an enzyme complex on the luminal membrane of the follicular cells. In its active state iodide participates in the iodination of tyrosine residues in thyroglobulin (for more details see Box 15.1). yroglobulin contains more than 120 tyrosine residues, although only the few that are accessible from the surface can be iodinated. e iodination reaction generates two intermediates: monoiodotyrosine (MIT) and diiodotyrosine (DIT), which remain attached to the
Box 15.1
Synthesis and release of thyroid hormones
Blood vessel
1
CH
2
OH
CH
2
OH
Tyrosine
residues on
thyroglobulin
CH
OH
CH
OH
2
I
HO
2
Follicular
cell
H
O
H
CCN
H
CH
2
II
O
HO
II
OH
T
4
H
O
CC
CH
H
N
H
2
II
O
I
OH
T
3
5
2
Lumen of follicle
I
CH
2
3
I
OH
CH
2
Coupling
II
4
OH
CH
2
II
O
MIT DIT
II
OH
T
4
CH
2
II
O
I
OH
T
3
Figure a
1. Iodide is actively transported from the blood by the iodide pump (Na+–I– symporter; NIS). The transport is driven by the electrochemical gradient for Na+ established by the Na+K+-ATPase (not shown). The activity of this transporter is switched on by activation of the receptors for thyroid-stimulating hormone (TSH) on the follicle cells, which also increases the synthesis of the transporter proteins.
2. The iodide diffuses across the follicular cell, and is transported into the colloid in the follicular lumen by a second transporter: pendrin, an I–/Cl– exchanger in the luminal membrane.
Box 15.1 Synthesis and release of thyroid hormones
3. The iodide interacts with the accessible tyrosine residues on thyroglobulin. (The glycoprotein thyroglobulin is produced by follicular cells, and is the main constituent of the colloid filling the follicle lumen.) Iodide is first oxidized in the presence of hydrogen peroxide (H2O2) to the highly reactive free radical I•. This is achieved by the thyroperoxidase enzyme complex located on the luminal side of the follicular cell membrane. The reactive iodide interacts with the phenyl grouping of the exposed tyrosine residues in thyroglobulin, forming two different products: monoiodotyrosine (MIT) and diiodotyrosine (DIT). This process is referred to as the organification of iodide. This is the site of action of thioureylenes (e.g. carbimazole and propylthiouracil).
4. Triiodothyronine (T3) and tetraiodothyronine (T4, thyroxine) are produced by coupling of MIT and DIT (one MIT combining with a DIT to produce T3, and two DITs yielding T4).
5. The thyroglobulin–T3/T4 complex enters the follicular cell where it is proteolytically cleaved by lysosomal enzymes to release T3/T4. These lipophilic molecules readily cross the plasma membrane to enter the blood.
DIT, diiodotyrosine; MIT, monoiodotyrosine; T3, triiodothyronine; T4, tetraiodothyronine (thyroxine).
thyroglobulin molecule. e nal stage of synthesis involves the coupling of MIT and DIT molecules. ese coupling reactions generate the completed thyroid hormones T3 and thyroxine (T4). e thyroid hormones, then, are synthesized within the structure of the thyroglobulin molecule, which therefore provides a store of hormones inside the follicles.
When stimulated to release thyroid hormones (see below), follicular cells endocytose a portion of the colloid containing the iodinated thyroglobulin. rough the action of proteolytic enzymes within these cells, the thyroid hormones are released from the thyroglobulin structure and are actively transported into the blood.
e lipophilic properties of T3 and T4 ensure that they rapidly bind to serum proteins in the blood, which transport them around the body. e hormones bind tightly to two proteins: thyroxine-binding globulin and transthyretin (thyroxine-binding pre-albumin). ey also bind to albumin, although less tightly. Very little of the thyroid hormones remains free: around 0.03% of T4 and 0.3% of T3. It is this free hormone which is able to enter target cells to cause an eect. As a consequence of binding to serum proteins, the thyroid hormones have long half-lives: around 1–3 days for T3, and 5–7 days for thyroxine. e blood can therefore be considered as a reservoir for both hormones, and in particular thyroxine, which is more strongly bound to serum proteins, as reected in its longer plasma half-life.
T3 is biologically more active than thyroxine, yet the thyroid gland secretes more thyroxine than T3, in the approximate
ratio 9:1. yroxine is itself subject to deiodination in many peripheral tissues, principally the kidneys and liver; around 90% of circulating T3 is derived from thyroxine in this way. e deiodinase enzymes that catalyse this conversion contain selenium. yroid hormone function is therefore dependent on two trace elements, iodine and selenium; deciencies in either can lead to severe hypothyroidism and endemic goitre (see below).
In a healthy individual, the levels of thyroid hormones in the plasma settle to constant values around 3 days after birth, and do not change signicantly throughout life.
15.1.2 Regulation of thyroid gland activity
e release of thyroxine and T3 from follicular cells into the blood follows activation of the thyroid glands by thyroid-stimulating hormone (TSH; also called thyrotrophin). is hormone is released by the anterior pituitary gland, and its secretion is in turn regulated by thyrotrophin-releasing hormone (TRH) from the hypothalamus (see Figure 15.2).
Production of the thyroid hormones only occurs when TSH stimulates its receptors on follicular cells. ese are G-protein-coupled receptors that show dual coupling to Gs and Gq; their activation leads to increases in cyclic AMP (through Gs) and increased inositol trisphosphate levels (through Gq). TSH stimulates all aspects of thyroid hormone synthesis and release, including the activity of the iodide pump and the production and iodination of thyroglobulin. TSH also maintains the structure and vascularization of the thyroid gland.